Vertigo Treatments Market Report 2024 (Global Edition)

Global Vertigo Treatments Market Report 2024 Market Size Split by Type (Peripheral Vertigo, Central Vertigo), by Treatment Type (Medication, Surgery), by Medication (Anticholinergics, Antihistamines, ...

Vertigo Treatments Market Report Description

We have various report editions of Vertigo Treatments Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Vertigo Treatments Market Insights Video

Competitive Landscape of the Vertigo Treatments Market

The major players in the foot vertigo treatments industry employ a wide range of tactics to maintain and grow their share of the global market. These include mergers and acquisitions, partnerships, collaboration, joint ventures, production process innovations, product line expansions, and improvements to existing products. They also seek out new customers in the endless vertigo treatments market worldwide.

July 2024: J&J announced that fresh non-clinical investigations would be presented, highlighting the molecular features of nipocalimab, an experimental, completely human monoclonal antibody that targets the postnatal fraction crystallizable receptor (FcRn). These results highlight the potential of nipocalimab as a top-tier FcRn blocker and its distinctive properties, such as its strong binding affinity and specificity for the FcRn immunoglobulin G (IgG) binding site. Its dose- and time-dependent receptor occupancy is a consequence of its properties and the dosage regimen that was used for the study. (Source: https://www.jnj.com/media-center/press-releases/unique-molecular-properties-of-nipocalimab-enabling-differentiated-potential-in-treating-generalized-myasthenia-gravis-to-be-presented-at-american-academy-of-neurologys-2024-annual-meeting) June 2024: Bayer declared its firm had secured a unique permit for an innovative biology pesticide by signing a deal with AlphaBio Command, a UK-based company. The newly developed good is expected to be the initial for crops, such as grains and oilseed rape, to be made affordable. This new pesticide was found by AlphaBio, for which Bayer distributes FLiPPER, a successful bioinsecticide-acaricide. Its initial launch is scheduled to take place, assuming further investigation and authorization. (Source: https://www.bayer.com/media/en-us/bayer-aims-to-launch-first-bioinsecticide-for-arable-crops/) June 2024: Takeda declared that the Japanese Ministry of Welfare, Labor, and Health (MHLW) accepted INTENSITY (maribavir) for the treatment of post-transplant CMV (cytomegalovirus) disorder or infection that is resistant to current anti-CMV medicines. The sole and initial post-transplant anti-CMV medication authorized in Japan is called INTENSITY, and it focuses on and restricts the pUL97 enzyme as well as its organic mediators. (Source: https://www.takeda.com/newsroom/newsreleases/2024/livtencity-japan-regulatory-approval/)

Top Companies Market Share in Vertigo Treatments Industry: (In no particular order of Rank)

• Pfizer Inc. (United States)
• Novartis AG (Switzerland)
• Abbott Laboratories (United States)
• Teva Pharmaceutical Industries Ltd (Israel)
• Bayer AG (Germany)
• GlaxoSmithKline plc (United Kingdom)
• Merck & Co.
• Inc. (United States)
• Sanofi S.A. (France)
• Johnson & Johnson (United States)
• AstraZeneca plc (United Kingdom)
• Bristol Myers Squibb (United States)
• Boehringer Ingelheim (Germany)
• Eisai Co.
• Ltd. (Japan)
• Mylan N.V. (Netherlands)
• Takeda Pharmaceutical Company Limited (Japan)
• Allergan plc (Ireland)
• Biogen Inc. (United States)
• Amgen Inc. (United States)
• Eli Lilly and Company (United States)
• Vertex Pharmaceuticals Incorporated (United States)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Vertigo Treatments Market

Which Region Dominates the Vertigo Treatments Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue because of the accessibility of cutting-edge medical facilities, the existence of important market participants, and advantageous financing guidelines. Furthermore, there is a greater understanding of the procedures used to manage vertigo disorders as part of routine examinations. The vertigo treatment industry is expanding in the area due to the method's low price and small risk in contrast to other treatments.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the vertigo treatments market because the area has a high proportion of elderly residents. This has led to an upsurge in vertigo instances. The worldwide vertigo treatment industry is also anticipated to be driven by the expansion of health-related facilities, the sharp rise in infectious instances, and an upsurge in auditory procedures.

The current report Scope analyzes Vertigo Treatments Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

North America Vertigo Treatments

According to Cognitive Market Research, the global vertigo treatments market size was estimated at USD 1465.6 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 586.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the vertigo treatments market with a market size of USD 462.54 million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. The nation's increasing investment in infrastructure.
• The Canada vertigo treatments market had a market share of USD 70.35 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Canada's rise is due to the nation's rapid expansion in the healthcare industry.
• The Mexico vertigo treatments market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 53.35 million in 2024.

Europe Vertigo Treatments

According to Cognitive Market Research, the global vertigo treatments market size was estimated at USD 1465.6 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 439.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031.

• The United Kingdom vertigo treatments market had a market share of USD 73.87 million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period. In the UK, vertigo treatments sales witness an upswing due to the nation's rising demand for innovative technology.
• The France vertigo treatments market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 40.45 million in 2024.
• According to Cognitive Market Research, the German vertigo treatments market size was valued at USD 87.06 million in 2024 and is projected to grow at a CAGR of 3.7% during the forecast period. In Germany, vertigo treatments surged due to the presence of major market players.
• The Italy vertigo treatments market is projected to witness growth at a CAGR of 2.9% during the forecast period, with a market size of USD 37.81 million in 2024.
• The Russia vertigo treatments market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 68.15 million in 2024.
• The Spain vertigo treatments market is projected to witness growth at a CAGR of 2.6% during the forecast period with a market size of USD 36.05 million in 2024
• The Luxembourg vertigo treatments market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD 13.63 million in 2024.
• The Portugal vertigo treatments market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 9.23 million in 2024.
• The Greece vertigo treatments market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 5.28 million in 2024.
• Rest of Europe's vertigo treatments market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 68.15 million in 2024.

Asia Pacific Vertigo Treatments

According to Cognitive Market Research, the global vertigo treatments market size was estimated at USD 1465.6 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 337.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• According to Cognitive Market Research, the China vertigo treatments market size was valued at USD 151.69 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period Vertigo treatments surged in China due to the adoption of various technologies.
• The Japan vertigo treatments market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 46.52 million in 2024.
• The India vertigo treatments market had a market share of USD 40.45 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. India's supportive initiatives taken by the government.
• The South Korean vertigo treatments market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 33.71 million in 2024.
• The Australian vertigo treatments market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 17.53 million in 2024.
• The South East Asia vertigo treatments market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 23.26 million in 2024.
• The Rest of Asia Pacific vertigo treatments market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 23.93 million in 2024.

South America Vertigo Treatments

According to Cognitive Market Research, the global vertigo treatments market size was estimated at USD 1465.6 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 73.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil vertigo treatments market size was valued at USD 31.36 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Vertigo treatments flourished in Brazil due to the innovation in customer habitats.
• Argentina's vertigo treatments market had a market share of USD 12.31 million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. Argentina's technological advancements augment the demand.
• Colombia vertigo treatments market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 6.52 million in 2024.
• Peru vertigo treatments market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 6.01 million in 2024.
• Chile vertigo treatments market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 5.28 million in 2024.
• The Rest of Latin America's vertigo treatments market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 11.80 million in 2024.

Middle East and Africa Vertigo Treatments

According to Cognitive Market Research, the global vertigo treatments market size was estimated at USD 1465.6 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 29.31 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031..

• The GCC Countries vertigo treatments market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 12.55 million in 2024 vertigo treatments sales flourish due to the presence of major market players.
• The Egypt vertigo treatments market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 3.08 million in 2024.
• The South Africa vertigo treatments market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 4.63 million in 2024. vertigo treatments sales flourish in South Africa due to technological advancements, and regulatory support.
• The Turkey vertigo treatments market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 2.52 million in 2024.
• The Nigeria vertigo treatments market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 3.08 million in 2024.
• The Rest of MEA vertigo treatments market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 3.46 million in 2024.

Vertigo Treatments Market Analysis

Vertigo Treatments Market Type Segment Analysis

According to Cognitive Market Research, peripheral stands out as the dominant category over the projected period because peripheral vertigo disorders are frequently more identifiable and diagnosable than centralized vertigo. More people may seek medical attention and prescription drugs to address their peripheral vertigo problems. Drug manufacturers may have achieved notable progress in treating peripheral vertigo diseases, resulting in more potent medications and treatments that could increase their market position.

Central vertigo emerges as the fastest-growing category in the vertigo treatments market because adolescent brain regions and cerebellar issues are on the rise. People with central vertigo can have better lives if they receive early detection and therapy. Sometimes, central vertigo develops when the brain is affected by an illness such as a cerebrovascular accident, sickness, or trauma injury. Extremely serious signs, like difficulty standing or extreme insecurity, are frequently experienced by those with central vertigo.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Vertigo Treatments Industry. Request a Free Sample PDF!

Vertigo Treatments Market Treatment Type Segment Analysis

According to Cognitive Market Research, the dominant category is medication because medication is usually finished quickly, and many patients prefer it to different kinds of therapy. The increasing number of medications and medicine types for vertigo around the world is fueling the market's expansion. Patients who have felt dizzy or nauseous as a result of vertigo can potentially benefit from medication for these adverse effects.

The fastest-growing category in the vertigo treatments market is surgery because of the accessible availability of several surgical procedures for vertigo and increasing recognition of the disorder. The most popular surgical technique for the therapy of uncontrollably chronic vertigo is labyrinthectomy. The market will expand as more less-invasive surgical methods for vertigo become available.

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Vertigo Treatments market report 2024 Edition by contacting our team.

Vertigo Treatments Medication Segment Analysis

Vertigo Treatments Market Medication Segment Analysis

According to Cognitive Market Research, the dominant category is anticholinergic because the majority of the many ailments that anticholinergic medications can aid in treating include indicators of neurological disorders, digestive disorders, urinary retention, and chronic pulmonary disease strictly prescriptions are accepted for anticholinergics.

The fastest-growing category in the vertigo treatments market is antihistamines. Because antihistamines are inexpensive, over-the-counter drugs are readily available, and the medication and the drug are highly effective in treating vertigo concerns. Antihistamines are medications that are frequently used to treat allergies, including asthma, itching, and attack or stings attacks from insects.

• Anticholinergics
• Antihistamines
• Others

Vertigo Treatments Distribution Channel Segment Analysis

Vertigo Treatments Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the dominant category is hospital pharmacies because recommended commodities have favorable health expenditures. Hospital pharmacists offer individualized vertigo care, which helps to advance the hospital pharmacy sector to unprecedented levels. Due to the need for a neurology evaluation, patients with essential vertigo are more likely to receive therapy in hospitals. This sector holds an enormous share due in part to the availability of sophisticated procedures for the diagnosis of vertigo.

The fastest-growing category in the vertigo treatments market is drug stores & retail pharmacies because more people are searching for treatment for vertigo-related disorders and because treatments are more readily available. Because retail stores offer quick accessibility to goods and personalized support. They provide medical supplies and prescription drugs to the general public as well as medical professionals. They also have a large range of personal hygiene products, art supplies, imaging gear, and wildlife supplies.

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Prescription Drugs
• OTC Drugs
• Online Providers

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion